<?xml version="1.0" encoding="UTF-8"?>
<ref id="B80-vaccines-07-00045">
 <label>80.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Francis</surname>
    <given-names>J.N.</given-names>
   </name>
   <name>
    <surname>Bunce</surname>
    <given-names>C.J.</given-names>
   </name>
   <name>
    <surname>Horlock</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Watson</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Warrington</surname>
    <given-names>S.J.</given-names>
   </name>
   <name>
    <surname>Georges</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Brown</surname>
    <given-names>C.B.</given-names>
   </name>
  </person-group>
  <article-title>A novel peptide-based pan-influenza A vaccine: A double blind, randomised clinical trial of immunogenicity and safety</article-title>
  <source>Vaccine</source>
  <year>2015</year>
  <volume>33</volume>
  <fpage>396</fpage>
  <lpage>402</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2014.06.006</pub-id>
  <?supplied-pmid 24928790?>
  <pub-id pub-id-type="pmid">24928790</pub-id>
 </element-citation>
</ref>
